Italy to improve regions uptake of anticancer reimbursement decisions
This article was originally published in Scrip
Executive Summary
Italy's ministry of health is going to sign an agreement with the country's 21 regions to stop them from delaying the uptake into their hospital positive lists the central reimbursement decisions made by the Italian Medicines Agency, AIFA, on "innovative" drugs, which usually includes expensive anticancers. The agreement, which was drawn up by the ministry of health, is expected to be signed within the next two months.